"Vertex's Non-Opioid Pain Drug Shows Promise in Late-Stage Trials"
TL;DR Summary
Vertex Pharmaceuticals' experimental non-opioid drug, VX-548, has shown promising results in two Phase III studies, with over 1,000 participants each, by significantly reducing post-surgery pain levels compared to a placebo. The drug's success marks a potential breakthrough in the search for non-addictive pain medication.
Topics:business#health#non-opioid#pain-drug#phase-iii-studies#post-surgery-pain-relief#vertex-pharmaceuticals
- Vertex's pain drug succeeds in late-stage studies, marking major breakthrough in search for new, non-opioid medicines Endpoints News
- Experimental Drug Cuts Off Pain at the Source, Company Says The New York Times
- Vertex says its experimental painkiller works as well as opioids for acute pain — without risk of addiction The Boston Globe
- Vertex non-opioid drug relieves pain in late-stage trials - STAT STAT
- Experimental pain drug may offer alternative to opioids for acute pain, study suggests CNN
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
0 min
vs 1 min read
Condensed
65%
124 → 44 words
Want the full story? Read the original article
Read on Endpoints News